Insider Trading History of Soteropoulos Paula

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Soteropoulos Paula since year 2005. The trader's CIK number is 1692444. At the time of the last reporting, Soteropoulos Paula was the Chief Executive Officer of Akcea Therapeutics, Inc. . (stock ticker symbol AKCA). See this page for all insider trading activities at Akcea Therapeutics, Inc. .

Note that in the past Soteropoulos Paula also reported insider trading activities as an insider of the following companies:

Insider Activities at Akcea Therapeutics, Inc. (AKCA)
Insider Activities at Uniqure N.v. (QURE)

Stock purchases, sales, and option exercises reported by insider *Soteropoulos Paula* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2019-04-08	AKCA	Akcea Therapeutics, Inc.	Option Ex	1,787	6.48	11,579
2019-04-05	AKCA	Akcea Therapeutics, Inc.	Sale	30,000	32.11	963,300
2019-04-05	AKCA	Akcea Therapeutics, Inc.	Option Ex	30,000	6.48	194,400
2019-04-08	AKCA	Akcea Therapeutics, Inc.	Sale	1,787	32.17	57,480
2019-03-06	AKCA	Akcea Therapeutics, Inc.	Sale	18,386	32.14	590,852
2019-03-06	AKCA	Akcea Therapeutics, Inc.	Option Ex	18,386	6.48	119,141
2019-01-28	QURE	Uniqure N.v.	Sale	1,210	31.32	37,897
2018-01-29	QURE	Uniqure N.v.	Sale	2,878	18.53	53,329

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Soteropoulos Paula (Chief Executive Officer of Akcea Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.